Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amit Tirosh

Showing results (21-30 of 101) with videos related to

Pageof 11
Sort By:
Population Health Management|March 30, 2013
The influence of age on the management of patients with diabetes in the Israeli populationAmit Tirosh, Zvi Stern, Marianna Mazar, et al.
American Journal of Medical Quality : the Official Journal of the American College of Medical Quality|January 12, 2008
Differences in quality of diabetes care between Jews and Arabs in JerusalemAmit Tirosh, Ronit Calderon-Margalit, Marianna Mazar, et al.
Hormones (Athens, Greece)|March 20, 2026
RET Lys666Asn has a low rate of MEN2-related tumors but may be associated with pheochromocytomaReut Halperin, Naama Peshes-Yaloz, Amit Tirosh, et al.
The Journal of Clinical Endocrinology and Metabolism|October 26, 2017
A Lymph Node Ratio-Based Staging Model Is Superior to the Current Staging System for Pancreatic Neuroendocrine TumorsApostolos Gaitanidis, Dhaval Patel, Naris Nilubol, et al.
Hormones (Athens, Greece)|May 31, 2024
Somatic USP8 alteration affects the immune landscape of corticotroph pituitary adenomas- a pilot studyDahlia Greidinger, Reut Halperin, Roni Zemet, et al.
Genetics Research|May 2, 2020
Germline variant in <i>REXO2</i> is a novel candidate gene in familial pheochromocytomaYael Laitman, Shay Tzur, Ruben Attai, et al.
Endocrine|July 4, 2019
Lower all-cause mortality rates in patients harboring pituitary carcinoma following the introduction of temozolomideGenya Aharon-Hananel, Ruth Percik, Muhamad Badarna, et al.
European Journal of Endocrinology|October 28, 2020
Pediatric Cushing's syndrome: greater risk of being overweight or obese after long-term remission and its predictive factorsNuria Valdés, Amit Tirosh, Meg Keil, et al.
European Journal of Endocrinology|July 13, 2019
Anatomic site as prognostic marker of pancreatic neuroendocrine tumors: a cohort studyMuhamad Badarna, Ruth Percik, Genya Aharon-Hananel, et al.
Annals of Surgical Oncology|November 15, 2017
Markers of Systemic Inflammatory Response are Prognostic Factors in Patients with Pancreatic Neuroendocrine Tumors (PNETs): A Prospective AnalysisApostolos Gaitanidis, Dhaval Patel, Naris Nilubol, et al.
Pageof 11

Showing results (21-30 of 101) with videos related to

Sort By:
Pageof 11
Population Health Management|March 30, 2013
The influence of age on the management of patients with diabetes in the Israeli populationAmit Tirosh, Zvi Stern, Marianna Mazar, et al.
American Journal of Medical Quality : the Official Journal of the American College of Medical Quality|January 12, 2008
Differences in quality of diabetes care between Jews and Arabs in JerusalemAmit Tirosh, Ronit Calderon-Margalit, Marianna Mazar, et al.
Hormones (Athens, Greece)|March 20, 2026
RET Lys666Asn has a low rate of MEN2-related tumors but may be associated with pheochromocytomaReut Halperin, Naama Peshes-Yaloz, Amit Tirosh, et al.
The Journal of Clinical Endocrinology and Metabolism|October 26, 2017
A Lymph Node Ratio-Based Staging Model Is Superior to the Current Staging System for Pancreatic Neuroendocrine TumorsApostolos Gaitanidis, Dhaval Patel, Naris Nilubol, et al.
Hormones (Athens, Greece)|May 31, 2024
Somatic USP8 alteration affects the immune landscape of corticotroph pituitary adenomas- a pilot studyDahlia Greidinger, Reut Halperin, Roni Zemet, et al.
Genetics Research|May 2, 2020
Germline variant in <i>REXO2</i> is a novel candidate gene in familial pheochromocytomaYael Laitman, Shay Tzur, Ruben Attai, et al.
Endocrine|July 4, 2019
Lower all-cause mortality rates in patients harboring pituitary carcinoma following the introduction of temozolomideGenya Aharon-Hananel, Ruth Percik, Muhamad Badarna, et al.
European Journal of Endocrinology|October 28, 2020
Pediatric Cushing's syndrome: greater risk of being overweight or obese after long-term remission and its predictive factorsNuria Valdés, Amit Tirosh, Meg Keil, et al.
European Journal of Endocrinology|July 13, 2019
Anatomic site as prognostic marker of pancreatic neuroendocrine tumors: a cohort studyMuhamad Badarna, Ruth Percik, Genya Aharon-Hananel, et al.
Annals of Surgical Oncology|November 15, 2017
Markers of Systemic Inflammatory Response are Prognostic Factors in Patients with Pancreatic Neuroendocrine Tumors (PNETs): A Prospective AnalysisApostolos Gaitanidis, Dhaval Patel, Naris Nilubol, et al.
Pageof 11